Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Deepak Chadha currently holds 22,314 shares of Brickell Biotech, Inc. (BBI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Deepak Chadha has been a net buyer of BBI stock. They have purchased $12.6K and sold $0 worth of shares.
Deepak Chadha's most recent insider trade was on Sep 1, 2023, when they sold 14,978 shares at $0.62 per share.
Deepak Chadha serves as Executive at Brickell Biotech, Inc. (BBI). They have executed 7 insider transactions totaling $12.6K over their tenure at the company.
Deepak Chadha holds the position of Executive at Brickell Biotech, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Deepak Chadha has shown a buying trading pattern, with $12.6K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Deepak Chadha was on May 19, 2021, when they purchased $10.4K worth of BBI shares. This transaction involved 12,500 shares at $0.83 per share.
Deepak Chadha currently owns 22,314 shares of Brickell Biotech, Inc. (BBI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Deepak Chadha's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Deepak Chadha has 7 Form 4 filings on record as an insider at Brickell Biotech, Inc..
Set alerts for Deepak Chadha and 40,000+ other insiders.